Disclosures for "Prophylactic Anti-Seizure Medication Use in Newly Diagnosed Brain Tumor Patients ")
-
Miss Jang has received personal compensation for serving as an employee of Eisai Inc.. Miss Jang has received research support from Eisai Inc..
-
Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vivacitas Oncology. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. The institution of Dr. Peters has received research support from Agios. The institution of Dr. Peters has received research support from Abbvie. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Educational Lecturer with Eisai.
-
Dr. Ngo has received personal compensation for serving as an employee of Eisai Inc..
-
An immediate family member of Dr. Morita has received personal compensation for serving as an employee of Forrester Research. An immediate family member of Dr. Morita has received stock or an ownership interest from Forrester Research. The institution of Dr. Morita has received research support from Cleveland Clinic.